Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
783
-
Total 13F shares, excl. options
-
276M
-
Shares change
-
+12.1M
-
Total reported value, excl. options
-
$9.7B
-
Value change
-
+$517M
-
Put/Call ratio
-
0.36
-
Number of buys
-
366
-
Number of sells
-
-329
-
Price
-
$35.14
Significant Holders of GSK plc - SPONSORED ADR (GSK) as of Q4 2022
899 filings reported holding GSK - GSK plc - SPONSORED ADR as of Q4 2022.
GSK plc - SPONSORED ADR (GSK) has 783 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 276M shares
.
Largest 10 shareholders include Dodge & Cox (64.9M shares), JTC Employer Solutions Trustee Ltd (18M shares), FMR LLC (15M shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (14M shares), Fisher Asset Management, LLC (12.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11.6M shares), GOLDMAN SACHS GROUP INC (9.71M shares), STATE STREET CORP (7.42M shares), ACADIAN ASSET MANAGEMENT LLC (6.56M shares), and Point72 Asset Management, L.P. (6.47M shares).
This table shows the top 783 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.